Bayer Said to Offer Assets, Cash in Race for Merck’s Unit

Bayer AG moved a step closer to winning Merck & Co.’s consumer business after lead rival Reckitt Benckiser Group Plc walked away from the deal because the asset became too expensive.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.